Brief: Tryptamine Therapeutics Announces A$6 Mln Funding
Oct 30 (Reuters) - Tryptamine Therapeutics Ltd TYP.AX :
* A$6M FUNDING TO FAST TRACK TRP-8803 CLINICAL TRIAL
STRATEGY
* FIRM COMMITMENTS TO RAISE A$6M AT A$0.02 PER NEW SHARE
Further company coverage: TYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt